SEC 13F Intelligence

Capwealth Advisors, LLC / CVS

Capwealth Advisors, LLC’s Cvs Health Corp Position

Does Capwealth Advisors, LLC own Cvs Health Corp (CVS)? Yes326.0K shares worth $23M (+1.74% of its 13F portfolio) as of Q1 2026, down from 328.3K shares the prior filed quarter.

Position Value
$23M
Q1 2026
Shares
326.0K
% of Portfolio
+1.74%
Quarters Held
30
currently held

Position History CVS

Reported value by quarter
Q4 ’18: $11MQ4 ’18Q1 ’19: $9MQ2 ’19: $10MQ3 ’19: $18MQ4 ’19: $21MQ4 ’19Q1 ’20: $17MQ2 ’20: $19MQ3 ’20: $16MQ4 ’20: $19MQ4 ’20Q1 ’21: $21MQ2 ’21: $24MQ3 ’21: $25MQ4 ’21: $31MQ4 ’21Q1 ’22: $30MQ2 ’22: $28MQ3 ’22: $28MQ4 ’22: $28MQ4 ’22Q1 ’23: $22MQ2 ’23: $22MQ3 ’23: $22MQ4 ’23: $25MQ4 ’23Q1 ’24: $26MQ2 ’24: $19MQ3 ’24: $21MQ4 ’24: $15MQ4 ’24Q1 ’25: $25MQ2 ’25: $23MQ3 ’25: $48MQ4 ’25: $26MQ4 ’25Q1 ’26: $23Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026326.0K$23M+1.74%
Q4 2025328.3K$26M+1.78%
Q3 2025637.8K$48M+1.87%
Q2 2025326.8K$23M+2.22%
Q1 2025361.9K$25M+2.65%
Q4 2024338.0K$15M+1.66%
Q3 2024332.6K$21M+2.27%
Q2 2024320.9K$19M+2.39%
Q1 2024321.2K$26M+2.88%
Q4 2023319.1K$25M+3.07%
Q3 2023322.1K$22M+2.89%
Q2 2023313.8K$22M+2.65%
Q1 2023295.3K$22M+2.74%
Q4 2022297.0K$28M+3.25%
Q3 2022297.0K$28M+3.74%
Q2 2022297.6K$28M+3.33%
Q1 2022293.8K$30M+3.04%
Q4 2021296.7K$31M+3.11%
Q3 2021296.2K$25M+2.75%
Q2 2021292.1K$24M+2.65%
Q1 2021281.8K$21M+2.41%
Q4 2020278.5K$19M+2.27%
Q3 2020281.4K$16M+2.19%
Q2 2020288.5K$19M+2.65%
Q1 2020283.3K$17M+2.96%
Q4 2019287.9K$21M+2.69%
Q3 2019284.0K$18M+2.38%
Q2 2019177.7K$10M+1.38%
Q1 2019170.0K$9M+1.41%
Q4 2018166.2K$11M+1.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capwealth Advisors, LLC’s full portfolio or all institutional holders of CVS.